Concepedia

Marko Poglitsch

MP

Statistics

Publications

62

Citations

4.6K

H-Index

33

Active since

2005

Affiliations

Medical University of Vienna(Current)

Ludwig Boltzmann Institute Applied Diagnostics

Erasmus MC

Vienna Biocenter

Sigmund Freud Privatuniversität Wien

Marko Poglitsch is an author at Medical University of Vienna specializing in medicine, pharmacology, and plasma renin activity.

ORCID

Publications per year

2005–2023

62

Publications

62

The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response

Thomas Weichhart, Giuseppina Costantino, Marko Poglitsch et al. · Immunity · 2008 · 802 citations · Full text

, , +14

Human recombinant soluble ACE2 in severe COVID-19

Alexander Zoufaly, Marko Poglitsch, Judith H. Aberle et al. · The Lancet Respiratory Medicine · 2020 · 429 citations · Full text

, , +2

Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects

Manuel Haschke, Manfred Schuster, Marko Poglitsch et al. · Clinical Pharmacokinetics · 2013 · 378 citations

, , +7

A Versatile Role of Mammalian Target of Rapamycin in Human Dendritic Cell Function and Differentiation

Michael Haidinger, Marko Poglitsch, René Geyeregger et al. · The Journal of Immunology · 2010 · 225 citations · Full text

, , +17

Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure

Ratnadeep Basu, Marko Poglitsch, Haran Yogasundaram et al. · Journal of the American College of Cardiology · 2017 · 197 citations

, , +14

1–5 of 62